Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8936 |
High Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8794 |
High Similarity |
NPD2796 |
Approved |
0.8733 |
High Similarity |
NPD7819 |
Suspended |
0.8503 |
High Similarity |
NPD6799 |
Approved |
0.8462 |
Intermediate Similarity |
NPD3748 |
Approved |
0.8431 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8356 |
Intermediate Similarity |
NPD1243 |
Approved |
0.8355 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8322 |
Intermediate Similarity |
NPD2533 |
Approved |
0.8322 |
Intermediate Similarity |
NPD2534 |
Approved |
0.8322 |
Intermediate Similarity |
NPD2532 |
Approved |
0.8289 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8247 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8219 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8219 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8212 |
Intermediate Similarity |
NPD920 |
Approved |
0.82 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8194 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8188 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.8182 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8176 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8169 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.8163 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8129 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8089 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8082 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.8079 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.8065 |
Intermediate Similarity |
NPD1934 |
Approved |
0.805 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8038 |
Intermediate Similarity |
NPD919 |
Approved |
0.8028 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.8013 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8013 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8012 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7987 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7987 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7974 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7962 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7961 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7933 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7931 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7911 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7908 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7905 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7877 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7871 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7862 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7862 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7843 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7826 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7823 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7821 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7817 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7817 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7799 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7799 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7778 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7758 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7758 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7748 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7748 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7744 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7718 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7711 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7697 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7697 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7683 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7683 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7683 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7679 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7671 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7671 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7669 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7669 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7667 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7665 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7643 |
Intermediate Similarity |
NPD17 |
Approved |
0.7639 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7628 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7622 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7619 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7616 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7606 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7605 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7582 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7574 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.755 |
Intermediate Similarity |
NPD6099 |
Approved |
0.755 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7545 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7535 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7535 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7517 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.75 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7485 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7483 |
Intermediate Similarity |
NPD1608 |
Approved |
0.747 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7467 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7456 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7455 |
Intermediate Similarity |
NPD6808 |
Phase 2 |
0.7453 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7448 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7447 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7432 |
Intermediate Similarity |
NPD411 |
Approved |
0.7432 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7415 |
Intermediate Similarity |
NPD1008 |
Clinical (unspecified phase) |
0.7412 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7407 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7407 |
Intermediate Similarity |
NPD4288 |
Approved |
0.74 |
Intermediate Similarity |
NPD1933 |
Approved |
0.74 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7397 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7394 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7391 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7389 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7368 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7365 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7353 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7349 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7337 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7333 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7329 |
Intermediate Similarity |
NPD5889 |
Approved |
0.7329 |
Intermediate Similarity |
NPD5890 |
Approved |
0.7329 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7315 |
Intermediate Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.7312 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7305 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7285 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7285 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7273 |
Intermediate Similarity |
NPD1778 |
Approved |
0.7273 |
Intermediate Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.726 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7254 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7246 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7241 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7233 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7219 |
Intermediate Similarity |
NPD2979 |
Phase 3 |
0.7215 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7208 |
Intermediate Similarity |
NPD2438 |
Suspended |
0.7202 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7197 |
Intermediate Similarity |
NPD3887 |
Approved |
0.7179 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7178 |
Intermediate Similarity |
NPD37 |
Approved |
0.7176 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7172 |
Intermediate Similarity |
NPD1281 |
Approved |
0.7171 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.716 |
Intermediate Similarity |
NPD6585 |
Discontinued |
0.7153 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7152 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7152 |
Intermediate Similarity |
NPD8032 |
Phase 2 |
0.7152 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7152 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD1876 |
Approved |
0.7143 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7143 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7135 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7113 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7105 |
Intermediate Similarity |
NPD3140 |
Approved |
0.7105 |
Intermediate Similarity |
NPD943 |
Approved |
0.7105 |
Intermediate Similarity |
NPD3142 |
Approved |
0.7103 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7097 |
Intermediate Similarity |
NPD4476 |
Approved |
0.7097 |
Intermediate Similarity |
NPD4477 |
Approved |
0.7089 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7088 |
Intermediate Similarity |
NPD8285 |
Discontinued |
0.7086 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7083 |
Intermediate Similarity |
NPD1651 |
Approved |
0.7083 |
Intermediate Similarity |
NPD5585 |
Approved |
0.7067 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7066 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7049 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7044 |
Intermediate Similarity |
NPD6652 |
Clinical (unspecified phase) |
0.7029 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7029 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7027 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7014 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7012 |
Intermediate Similarity |
NPD6385 |
Approved |
0.7012 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7012 |
Intermediate Similarity |
NPD6386 |
Approved |
0.7006 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7006 |
Intermediate Similarity |
NPD6971 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD7837 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.6993 |
Remote Similarity |
NPD4060 |
Phase 1 |
0.6987 |
Remote Similarity |
NPD5404 |
Approved |
0.6987 |
Remote Similarity |
NPD5405 |
Approved |
0.6987 |
Remote Similarity |
NPD2531 |
Phase 2 |
0.6987 |
Remote Similarity |
NPD5406 |
Approved |
0.6987 |
Remote Similarity |
NPD5408 |
Approved |
0.6978 |
Remote Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.6977 |
Remote Similarity |
NPD7177 |
Discontinued |
0.6974 |
Remote Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.6974 |
Remote Similarity |
NPD3764 |
Approved |
0.697 |
Remote Similarity |
NPD6279 |
Approved |
0.697 |
Remote Similarity |
NPD6844 |
Discontinued |
0.697 |
Remote Similarity |
NPD6280 |
Approved |
0.6961 |
Remote Similarity |
NPD4360 |
Phase 2 |
0.6961
|
Remote Similarity |
NPD4363 |
Phase 3 |